GDF15 and Mitochondrial myopathy: Finally, circulating GDF‐15 was elevated in patients and preclinical models of primary mitochondrial myopathy, and administration of a blocking antibody was associated with an improved muscle phenotype in mice expressing a proofreading‐deficient version of the mitochondrial DNA polymerase gamma, leading to an increased rate of mutations in mitochondrial DNA [40].